This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

New Developments in the Treatment of ADHD.

Joseph Biederman, M.D.; Amy F. T. Arnsten, Ph.D.; Stephen V. Faraone, Ph.D.; Alysa E. Doyle, Ph.D.; Thomas J. Spencer, M.D.; Timothy E. Wilens, M.D.; Margaret D. Weiss, M.D., Ph.D.; Steven A. Safren, Ph.D.; and Larry Culpepper, M.D., M.P.H.

Published: January 16, 2006

Article Abstract

Click to enlarge page

Introducing the topic, Joseph Biederman, M.D., explained that new developments in the treatment of attention-deficit/hyperactivity disorder (ADHD) include more than useful medications. New developments relate to recent neurobiological research findings, research on comorbid diagnoses, explanations of drug mechanisms of action, nonpharmacologic treatment recommendations, and the role that primary care physicians play in treatment of the disorder.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: ADHD , Neurodevelopmental

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...